Concepedia

Sherly Mardiana

SM

Statistics

Publications

9

Citations

1.8K

H-Index

9

Active since

2016

Affiliations

Peter MacCallum Cancer Centre(Current)

The University of Melbourne

Monash University

Sherly Mardiana is an author at Peter MacCallum Cancer Centre specializing in medicine, immunology, and cell biology.

ORCID

Top concepts

Publications per year

2016–2021

9

Publications

9

Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade

Imran G. House, Peter Savas, Junyun Lai et al. · Clinical Cancer Research · 2019 · 689 citations

Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy

Paul A. Beavis, Melissa A. Henderson, Lauren Giuffrida et al. · Journal of Clinical Investigation · 2017 · 309 citations · Full text

, , +15

Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity

Junyun Lai, Sherly Mardiana, Imran G. House et al. · Nature Immunology · 2020 · 207 citations

, , +11

CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy

Lauren Giuffrida, Kevin Sek, Melissa A. Henderson et al. · Nature Communications · 2021 · 194 citations · Full text

Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting

Clare Y. Slaney, Bianca von Scheidt, Alexander J. Davenport et al. · Clinical Cancer Research · 2016 · 115 citations · Full text

Rows per page

1–5 of 9